Loading...
Loading...
India's heparin imports from UNITED STATES total $14.8M across 41 shipments from 15 foreign suppliers. PFIZER SERVICE COMPANY BV leads with $8.5M in import value; the top 5 suppliers together control 99.9% of this origin. Leading Indian buyers include PFIZER HEALTHCARE INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for heparin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

PFIZER SERVICE COMPANY BV is the leading Heparin supplier from UNITED STATES to India, with import value of $8.5M across 1 shipments. The top 5 suppliers — PFIZER SERVICE COMPANY BV, XXIZEXXSERXXCE XXMPAXX BV, R2 DIAGNOSTICS, INC., U.S.PHARMACOPEIAL CONVENTION., SMITHFIELD BIOSCIENCE — collectively account for 99.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PFIZER SERVICE COMPANY BV | $8.5M | 1 | 57.2% |
| 2 | XXIZEXXSERXXCE XXMPAXX BV | $6.2M | 2 | 41.8% |
| 3 | R2 DIAGNOSTICS, INC. | $120.8K | 4 | 0.8% |
| 4 | U.S.PHARMACOPEIAL CONVENTION. | $5.3K | 4 | 0.0% |
| 5 | SMITHFIELD BIOSCIENCE | $4.7K | 3 | 0.0% |
| 6 | RAFF HALL PHARMACY | $3.5K | 1 | 0.0% |
| 7 | RAFF & HALL PHARMACY | $3.4K | 1 | 0.0% |
| 8 | USP | $2.2K | 4 | 0.0% |
| 9 | SPRING BIO SOLUTION LTD | $2.1K | 5 | 0.0% |
| 10 | UNITED STATES PHARMACOPEIAL CONVENTION | $1.8K | 1 | 0.0% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC | $1.3K | 1 | 0.0% |
| 12 | NEW CITY RX LLC | $916 | 1 | 0.0% |
| 13 | SAVI CLINICALS FZ LLC | $771 | 1 | 0.0% |
| 14 | NEWLIFE MEDICALS (USA). INC. | $654 | 2 | 0.0% |
| 15 | RTI INTERNATIONAL-ROC | $596 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $14.7M | 3 | 99.0% |
| 2 | R2 HEMOSTASIS DIAGNOSTICS INDIA PRIVATE LIMITED | $120.8K | 4 | 0.8% |
| 3 | UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED | $9.2K | 6 | 0.1% |
| 4 | CIPLA LIMITED | $6.9K | 2 | 0.0% |
| 5 | BIOLOGICAL E. LIMITED | $5.6K | 5 | 0.0% |
| 6 | AUROBINDO PHARMA LTD | $2.2K | 6 | 0.0% |
| 7 | FRESENIUS KABI ONCOLOGY LIMITED | $1.3K | 1 | 0.0% |
| 8 | BIOLOGICAL E LIMITED | $771 | 1 | 0.0% |
| 9 | GLAND PHARMA LTD | $654 | 2 | 0.0% |
| 10 | GEORGE INSTITUTE FOR GLOBAL HEALTH | $596 | 1 | 0.0% |
| 11 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $472 | 2 | 0.0% |
| 12 | EUGIA PHARMA SPECIALITIES LIMITED | $438 | 1 | 0.0% |
| 13 | CHROMACHEMIE LABORATORY PRIVATE LIMITED | $325 | 1 | 0.0% |
| 14 | EXTROVIS PRIVATE LIMITED | $98 | 1 | 0.0% |
| 15 | AUROBINDO PHARMA LIMITED | $17 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Heparin suppliers from UNITED STATES to India include PFIZER SERVICE COMPANY BV, XXIZEXXSERXXCE XXMPAXX BV, R2 DIAGNOSTICS, INC.. The leading supplier is PFIZER SERVICE COMPANY BV with import value of $8.5M USD across 1 shipments. India imported Heparin worth $14.8M USD from UNITED STATES in total across 41 shipments.
India imported Heparin worth $14.8M USD from UNITED STATES across 41 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Heparin sourced from UNITED STATES include PFIZER HEALTHCARE INDIA PRIVATE LIMITED, R2 HEMOSTASIS DIAGNOSTICS INDIA PRIVATE LIMITED, UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED. The largest buyer is PFIZER HEALTHCARE INDIA PRIVATE LIMITED with $14.7M in imports across 3 shipments.
The total value of Heparin imports from UNITED STATES to India is $14.8M USD, across 41 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
41 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists